NCT00501878View on ClinicalTrials.gov

2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented Irides

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2007

Study Completion Date

July 31, 2007

Conditions
Diabetes Mellitus
Interventions
DRUG

2.5% or 10% phenylephrine

Trial Locations (1)

40002

Srinagarind Hospital Eye Clinic, Khon Kaen

All Listed Sponsors
lead

Khon Kaen University

OTHER

NCT00501878 - 2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented Irides | Biotech Hunter | Biotech Hunter